What does Dr. Andrea Sarkozy Cardiologie do?

Dr. Andrea Sarkozy Cardiologie is a specialist medical practice in Antwerpen. Private Limited, started on 12 December 2022, 1 establishment.

What is the address of Dr. Andrea Sarkozy Cardiologie?

The registered office of Dr. Andrea Sarkozy Cardiologie is located at Kerkelei 54, 2610 Antwerpen.

Is Dr. Andrea Sarkozy Cardiologie still active?

Yes. According to the CBE (5 October 2026) Dr. Andrea Sarkozy Cardiologie is active, legal situation “Normale toestand”, started on 12 December 2022.

Is Dr. Andrea Sarkozy Cardiologie registered on Peppol?

Yes, Dr. Andrea Sarkozy Cardiologie is registered on the Peppol network with ID 0208:0794673389.

What is the enterprise number of Dr. Andrea Sarkozy Cardiologie?

The enterprise number of Dr. Andrea Sarkozy Cardiologie is BE0794673389.

When was Dr. Andrea Sarkozy Cardiologie founded?

Dr. Andrea Sarkozy Cardiologie was founded on 12 December 2022.

Who are the directors of Dr. Andrea Sarkozy Cardiologie?

According to the 2025 annual accounts, the directors of Dr. Andrea Sarkozy Cardiologie are: Andrea Sarkozy.

Is Dr. Andrea Sarkozy Cardiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 December 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Andrea Sarkozy Cardiologie make in 2025?

Dr. Andrea Sarkozy Cardiologie posted a profit after taxes of € 247,129 in financial year 2025.

What is the revenue of Dr. Andrea Sarkozy Cardiologie?

As a small company, Dr. Andrea Sarkozy Cardiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 338,155.

Dr. Andrea Sarkozy Cardiologie (Private Limited)

Dossier Dr. Andrea Sarkozy Cardiologie, printed on 5 October 2026 from databakkes.be/en/0794673389/dr-andrea-sarkozy-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Andrea Sarkozy Cardiologie from Antwerpen, company number BE0794673389, closed financial year 2025 with a result of € 247,129 after tax. For that financial year Dr. Andrea Sarkozy Cardiologie recorded a gross margin of € 338,155 and equity of € 2,081. Compared with financial year 2024, the result moved from € 221,351 to € 247,129. Profitable, and profit is growing. The buffer shrank hard: equity is 100 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Shrank hard

€ 2,081

▼ € 425,971 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 247,129

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 4,759

▼ 94% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 673,100 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 14,018

▲ 83% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 61,371

▲ 50% vs 2024

€ 47,941 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 12,523

▲ 77% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 91,414

▲ 31% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -203 Gross margin 2022: € -203 First fiscal year in the series	€ 273,639 Gross margin 2023: € 273,639 ▲ € 273,842 vs 2022 (€ -203) Favourable step	€ 296,868 Gross margin 2024: € 296,868 ▲ 8% vs 2023 (€ 273,639) Favourable step	€ 338,155 Gross margin 2025: € 338,155 ▲ 14% vs 2024 (€ 296,868) Favourable step	▲ 14%
Profit after taxes	€ -272 Profit after taxes 2022: € -272 First fiscal year in the series	€ 204,974 Profit after taxes 2023: € 204,974 ▲ € 205,246 vs 2022 (€ -272) Favourable step	€ 221,351 Profit after taxes 2024: € 221,351 ▲ 8% vs 2023 (€ 204,974) Favourable step	€ 247,129 Profit after taxes 2025: € 247,129 ▲ 12% vs 2024 (€ 221,351) Favourable step	▲ 12%
Equity	€ 1,728 Equity 2022: € 1,728 First fiscal year in the series	€ 206,701 Equity 2023: € 206,701 ▲ € 204,974 vs 2022 (€ 1,728) Favourable step	€ 428,053 Equity 2024: € 428,053 ▲ 107% vs 2023 (€ 206,701) Favourable step	€ 2,081 Equity 2025: € 2,081 ▼ € 425,971 vs 2024 (€ 428,053) Unfavourable step	▼ € 425,971
Total debts	€ 2,915 Total debts 2022: € 2,915 First fiscal year in the series	€ 128,996 Total debts 2023: € 128,996 ▲ € 126,081 vs 2022 (€ 2,915) Unfavourable step	€ 125,263 Total debts 2024: € 125,263 ▼ 3% vs 2023 (€ 128,996) Favourable step	€ 412,409 Total debts 2025: € 412,409 ▲ 229% vs 2024 (€ 125,263) Unfavourable step	▲ 229%
Cash	€ 2,000 Cash 2022: € 2,000 First fiscal year in the series	€ 140,783 Cash 2023: € 140,783 ▲ € 138,783 vs 2022 (€ 2,000) Favourable step	€ 81,687 Cash 2024: € 81,687 ▼ 42% vs 2023 (€ 140,783) Unfavourable step	€ 4,759 Cash 2025: € 4,759 ▼ 94% vs 2024 (€ 81,687) Unfavourable step	▼ 94%
Retained profit	€ -272 Retained profit 2022: € -272 First fiscal year in the series	€ 204,701 Retained profit 2023: € 204,701 ▲ € 204,974 vs 2022 (€ -272) Favourable step	€ 426,053 Retained profit 2024: € 426,053 ▲ 108% vs 2023 (€ 204,701) Favourable step	€ 81 Retained profit 2025: € 81 ▼ € 425,971 vs 2024 (€ 426,053) Unfavourable step	▼ € 425,971
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 673,100 Dividend 2025: € 673,100 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 53,946 Bank debt 2023: € 53,946 Unchanged (€ 0) Unfavourable step	€ 41,002 Bank debt 2024: € 41,002 ▼ 24% vs 2023 (€ 53,946) Favourable step	€ 61,371 Bank debt 2025: € 61,371 ▲ 50% vs 2024 (€ 41,002) Unfavourable step	▲ 50%
Balance sheet total	€ 4,643 Balance sheet total 2022: € 4,643 First fiscal year in the series	€ 335,697 Balance sheet total 2023: € 335,697 ▲ € 331,055 vs 2022 (€ 4,643) Unchanged	€ 553,315 Balance sheet total 2024: € 553,315 ▲ 65% vs 2023 (€ 335,697) Unchanged	€ 414,490 Balance sheet total 2025: € 414,490 ▼ 25% vs 2024 (€ 553,315) Unchanged	▼ 25%

Key figures of Dr. Andrea Sarkozy Cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Andrea Sarkozy Cardiologie?

What happened at Dr. Andrea Sarkozy Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: profit of € 247,129 (▲ 12% vs 2024). Source: NBB ↗
Dec 12, 2022 New establishment in Mechelen. KBO
2022 Andrea Sarkozy became a director. NBB
Dec 12, 2022 Start of the company according to the CBE. KBO

In short

From € 273 loss in 2022 to € 247,129 profit in 2025.

Paid € 217,265 in corporate taxes since 2022.

Best year ever: 2025, with € 247,129 profit.

Paid out € 673,100 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Andrea Sarkozy Cardiologie? We notify you, reason included.

Follow Dr. Andrea Sarkozy Cardiologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Andrea Sarkozy

Dr. Andrea Sarkozy Cardiologie

Behind Dr. Andrea Sarkozy Cardiologie is Andrea Sarkozy.

See the full network in the app

Directors

According to the 2025 annual accounts

Andrea Sarkozy

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkelei 54

2610 Antwerpen

2.339.886.062

Onze-Lieve-Vrouwestraat 89

2800 Mechelen

Active since 12 December 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0794.673.389
VAT number: BE 0794.673.389
Registered office: Kerkelei 54, 2610 Antwerpen
Names & denominations: Dr. Andrea Sarkozy Cardiologie · Dr. Sarkozy
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 December 2022
Peppol: Active · Active since 2 Sept 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗